αHBV/HDVlamda

Sarah Duehren1, Takuro Uchida2, Masataka Tsuge3

  • 1The Program for Experimental and Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.

Virus research
|August 21, 2024
PubMed
概括

基化干扰素-α (IFNα) 在减少B型肝炎病毒 (HBV) 和D型肝炎病毒 (HDV) 在缺乏自适应免疫力的人性化小鼠中,比基化干扰素-lambda (IFNλ) 具有更高的疗效.